News

Qilu was awarded for two products

ABOUT US

News

Qilu was awarded for two products

Release time：

2012-03-06

Shandong provincial Party committee and provincial government held provincial science and technology awarding meeting in Jinan on Feb.16.

Qilu Pharma won provincial scientific and technological progress first prize for34 achievements, including Pemetrexed disodium.Pemetrexed Disodium developped by Qilu pharma is new into clinical, multitargeted and folic acid resistance oncology drugs and used for the treatment of lung cancer,tumors of the skin between pleura and so on. It is recognized as oncology drugs with most clinical value this year.

The state council of the communist party held national science and technology awarding meeting in Beijing on Feb.14. Qilu Pharma won national science and technology progress second prize for Recombinant human interleukin (11) development and key technology industrialization.

The achievement of the prize is the high recognition for the technology,product quality and market performance of Recombinant human interleukin (11) from the country.It is the result of development strategy implement and the scientific research team effort and it is the affirmation of the overall strength of our company.

Ms. Li Yan, awarded as Person of 2011 for Economy in Jinan

Mr.Wang Jingyi, was awarded the highest prize for Science & Technology from Jinan Gov

Related News

Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

2023-10-12

Qilu Pharmaceutical launched the first innovative drug in China

2023-09-01

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

2023-04-04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”

2022-12-19

Qilu Pharmaceutical ranked 5th among China's top 100 list